Shanghai Shen Lian Biomedical Corp (688098) — Capital Reinvestment Ratio
Shanghai Shen Lian Biomedical Corp (688098) has a Capital Reinvestment Ratio of 0.59x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥21.52 Million) in capital expenditures (CN¥12.62 Million). See 688098 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Shen Lian Biomedical Corp Capital Reinvestment Ratio (2013–2025)
This chart tracks Shanghai Shen Lian Biomedical Corp's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Shen Lian Biomedical Corp (2013–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Shen Lian Biomedical Corp from 2013 to 2025. For live market cap and broader valuation context, see Shanghai Shen Lian Biomedical Corp stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | CN¥33.08 Million | CN¥45.23 Million | ▲ +43.9% |
| 2024 | 0.95x | CN¥89.36 Million | CN¥84.91 Million | ▼ -97.4% |
| 2023 | 36.77x | CN¥3.53 Million | CN¥129.63 Million | ▲ +258.8% |
| 2022 | 10.25x | CN¥9.09 Million | CN¥93.12 Million | ▲ +390.8% |
| 2021 | 2.09x | CN¥90.12 Million | CN¥188.16 Million | ▲ +42.6% |
| 2020 | 1.46x | CN¥111.73 Million | CN¥163.56 Million | ▼ -24.3% |
| 2019 | 1.93x | CN¥53.81 Million | CN¥104.09 Million | ▲ +197.3% |
| 2018 | 0.65x | CN¥121.13 Million | CN¥78.80 Million | ▼ -53.1% |
| 2017 | 1.39x | CN¥74.61 Million | CN¥103.44 Million | ▼ -42.5% |
| 2016 | 2.41x | CN¥48.00 Million | CN¥115.70 Million | ▲ +77.4% |
| 2015 | 1.36x | CN¥30.86 Million | CN¥41.93 Million | ▲ +356.1% |
| 2014 | 0.30x | CN¥105.98 Million | CN¥31.57 Million | ▼ -56.2% |
| 2013 | 0.68x | CN¥51.79 Million | CN¥35.23 Million | — |